Rayno 2009 Biotechnology Portfolio-Mid Year Update
The Rayno Biopharm Portfolio is flat YTD. This compares to the broad-based ETF IBB which also flat YTD and the XBI which is down 5% YTD. Biotech in 2009 has significantly lagged the NASDAQ which is up 11%, however the S&P 500 is down 2.7% YTD. The Rayno portfolio consists of 24 stocks weighted...
Reflation Trade kicks back: stay cautious
The gloomy job report has risk traders seeking cash. * The Dow,S&P and Nasdaq were all down 2.6% +. * Money flowed into the Dollar and US Treasuries as investors were seeking safety. * Precious metal stocks were down 3%; gold was down 1.25%. * The energy sector was hard hit as oil sold off 3.7%...
Reflation trade turns cautious: 3% Market Sell-Off
The market had a broadbase sell-off today with weakness in all sectors especially commodity stocks such as energy and materials. The 30% rally since March 9th has come to a screeching halt. A global growth warning from the World bank gave a bleak report cutting estimates for 2009 from a 1.7%...
H1N1 Flu Pandemic is here but Moderate in Severity
Drug Stocks rally on Flu News On Thursday June 11,the WHO raised its alert on swine flu (H1N1) to the Phase 6 pandemic level calling further spread of the virus inevitable. The Director- General of WHO Dr. Margaret Chan said, "Globally we have good reason to believe that this pandemic, at least...
Ten Year Treasury Auction drives Yield to 3.99%
The reflation trade got a big boost from Treasuries today as the latest auction brought yields of close to 4%, much higher than the pricing of the May 9th delayed auction when yields were about 3.19%. The ongoing run on oil didn't help matters as crude futures rose to $71.83 a rise of 1.84% a...